Physician profile

Asim J Chohan

Cardiovascular Disease · Midwest City, OK

NPI 1386793156

$19,179.28

in general payments reported to CMS, 2019-2025

47 companies · $2,457 in 2025

The $2,457 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,921.07
Travel and Lodging$255.14
Education$25.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $3,472.53 2022-2025 Watchman Flx, Baylis Medical Company Radiofrequency Puncture Generator, Versacross Access Solution
Astrazeneca Pharmaceuticals LP $1,301.03 2019-2025 Farxiga, Wainua, Airsupra
Amgen INC. $1,268.01 2019-2025 Repatha, Repatha
Edwards Lifesciences Corporation $1,246.51 2019-2022
Pfizer INC. $1,175.63 2019-2025
Janssen Pharmaceuticals, INC $1,003.85 2019-2024 Xarelto
Abbott Laboratories $902.22 2019-2025 Pressurewire, Xience Sierra, Mitraclip
Abiomed $870.35 2021-2025 Impella
Novartis Pharmaceuticals Corporation $851.63 2019-2025
E.R. Squibb & Sons, L.L.C. $822.52 2020-2025 Camzyos, Eliquis
Boehringer Ingelheim Pharmaceuticals, INC. $768.27 2019-2025 Jardiance
Medtronic Vascular, INC. $738.87 2019-2020
Merck Sharp & Dohme LLC $642.32 2021-2025 Verquvo, Capvaxive
Impulse Dynamics (USA) INC. $603.86 2023-2025 Optimizer, Optimizer
Novo Nordisk INC $326.84 2020-2025 Wegovy, Ozempic, Rybelsus
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Amarin Pharma, INC. $308.32 2020-2021
Medtronic, INC. $300.77 2022-2025 Micra, Cobalt Dr Mri Surescan, Hawkone
Cvrx, INC. $283.54 2021-2025 Barostim Neo System
Bayer Healthcare Pharmaceuticals INC. $234.21 2021-2025
Lexicon Pharmaceuticals, INC. $228.32 2023-2024 Inpefa
Esperion Therapeutics, INC. $221.51 2020-2025 Nexletol
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $217.35 2019-2025 Lifevest
Bolton Medical INC $152.31 2019
Philips North America LLC $142.54 2020-2024 (Ck4) Mcot
Lundbeck LLC $126.38 2019-2021
Chiesi USA, INC. $112.68 2020-2023 Kengreal, Cleviprex
Pulmonx Corporation $99.14 2024 Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console
Alnylam Pharmaceuticals INC. $92.32 2022-2024 Onpattro
Inari Medical, INC. $90.07 2022-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Regeneron Healthcare Solutions, INC. $75.51 2019
Kowa Pharmaceuticals America, INC. $56.51 2019-2024 Livalo
Glaxosmithkline, LLC. $51.71 2022-2023 Trelegy Ellipta
Becton, Dickinson and Company $46.88 2025
Baxter Healthcare $42.29 2023-2025 Hillrom - Carnation Ambulatory Monitor, Biopharma Sol - Contract Manuf
Kiniksa Pharmaceuticals, LTD. $35.74 2022-2023 Arcalyst
Sanofi-Aventis U.S. LLC $34.76 2021
Stryker Corporation $34.18 2025 Clottriever Bold Catheter
Kiniksa Pharmaceuticals International, Plc $31.62 2024 Arcalyst
Bardy Diagnostics, INC. $26.98 2020-2021
Althera Pharmaceuticals LLC $24.45 2021-2022
Scpharmaceuticals INC. $23.65 2025
Si-Bone, INC. $19.66 2022
Celonova Biosciences, INC. $18.65 2019
Atricure, INC. $14.27 2024
Janssen Biotech, INC. $13.81 2020
Irhythm Technologies, INC. $13.17 2024 Zio Monitor, Zio Xt Patch
Teleflex LLC $11.54 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Asim J Chohan

$19,179.28

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $2,457 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/17107/asim-j-chohan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.